“…However, this often requires the destabilization of the native protein structure, for instance, by non-physiological pH, ionic strength, temperature, or monomer concentration. While it was already shown thirty years ago that the presence of interfaces can also stimulate protein and peptide aggregation [ 31 ], surface- and interface-related effects have only recently become a focus of attention [ 32 , 33 , 34 ]. This recent development was mostly motivated by the potential of nanoparticle-based strategies to mitigate amyloid-associated diseases [ 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 ], as well as by promising applications of amyloid fibrils in materials’ synthesis [ 44 , 45 , 46 , 47 , 48 ].…”